Top Medical News
Erenumab works well in chronic migraine patients across Asia
Jairia Dela Cruz, 40 minutes ago
Erenumab proves to be effective at lowering the number of monthly migraine days in Asian patients with chronic migraine while having a favourable safety profile, according to the results of DRAGON study.
Low choline intake ups risk of dementia, Alzheimer's disease
3 hours ago
Low intake of dietary choline may increase the risk of incident dementia and Alzheimer’s disease (AD), a recent study has found.
Early menopause tied to increased dementia risk
6 hours ago
There appears to be no longitudinal association between hair cortisol and cortisone levels with dementia and various measures of cognitive function, a recent study has found.
Stroke up 30 percent since 2001 in HK’s ≤55-year-olds
Natalia Reoutova, 22 hours ago

Researchers from the University of Hong Kong (HKU) report that the incidence of “young stroke” (ie, strokes occurring in those aged 18–55 years) has increased by 30 percent in Hong Kong’s residents since 2001.

Group CBT may help improve emotion regulation in adults with autism
2 days ago
Among adults with autism spectrum disorder (ASD), group-based cognitive behavioural therapy (CBT) appears to yield modest improvements in emotion regulation, a recent study has found.
ADHD medication use carries no excess risk of cardiovascular diseases
3 days ago
Users of attention-deficit/hyperactivity disorder (ADHD) medications across age groups do not appear to be at increased risk of cardiovascular diseases (CVDs), although a modest risk increase of cardiac arrest or tachyarrhythmias could not be ruled out, according to the results of a meta-analysis.
ENT-01 relieves constipation in patients with Parkinson’s disease
4 days ago
Oral ENT-01 safely and significantly improves constipation in patients with Parkinson’s disease (PD), results of a phase IIb study have shown.
Special Reports
Product Highlight - Pontevia
16 Mar 2022
Galcanezumab Injection
Shifting paradigms in MS management: Early, optimized interventions improve patient outcomes
04 May 2018
Multiple sclerosis (MS) is one of the most common neurological disorders – affecting over 2.3 million people globally – and it is the leading cause of nontraumatic disability in young adults. However,the availability of supportive resources and services for people with MS is scarce in many regions of the world. In Malaysia, the prevalence of MS is estimated at 2-3/100,000; the current Malaysian clinical practice guidelines on the management of MS recommend disease modifying agents, such as interferon-β and teriflunomide, as first-line therapeutic agents. In this article, Dr Singer - in partnership with Sanofi and the Malaysian Society of Neurosciences - shares his insights into managing MS dynamically, highlighting the importance of early intervention in improving patient outcomes.
Conference Reports
CT angiography may increase potential recipients of EVT for acute ischaemic stroke
Roshini Claire Anthony, 27 Nov 2022

Using collateral flow findings, as seen on computed tomographic (CT) angiography, may widen the population who can undergo late endovascular treatment (EVT) for acute ischaemic stroke (AIS), according to findings of the MR CLEAN-LATE trial.

Intensive BP-lowering a no-go after reperfusion in ischaemic stroke
Roshini Claire Anthony, 14 Nov 2022

An intensive blood pressure target (<120 mm Hg) should be avoided in patients who have undergone endovascular thrombectomy for acute ischaemic stroke (AIS) for large-vessel occlusion (LVO), results of the phase III ENCHANTED2/MT* trial showed.

Higher ultra-processed food intake tied to faster cognitive decline
Elaine Soliven, 14 Sep 2022
High consumption of ultra-processed food (UPF) appears to be associated with a rapid decline in cognitive function in adults, according to the ELSA-Brasil* study presented at AAIC 2022.
Hypertensive disorders of pregnancy: A risk factor for dementia?
Roshini Claire Anthony, 05 Sep 2022

Individuals with a history of hypertensive disorders of pregnancy (HDP) appear to have an increased risk of developing dementia, particularly vascular dementia, according to a study presented at AAIC 2022.

ICU admission tied to dementia risk
Roshini Claire Anthony, 30 Aug 2022

Older adults who have been admitted to the intensive care unit (ICU) may have an elevated risk of developing Alzheimer’s dementia or all types of dementia, according to a study presented at AAIC 2022.

Brexpiprazole shows promise in reducing agitation due to Alzheimer’s dementia
Elaine Soliven, 26 Aug 2022
Treatment with brexpiprazole at either 2 or 3 mg significantly reduced agitation compared with placebo in patients with Alzheimer’s dementia, according to the Trial 331-14-213* presented at AAIC 2022.
Dancing protective against AD, dementia?
Audrey Abella, 17 Aug 2022
Studies presented at AAIC 2022 show that dancing could be a protective factor against the development of Alzheimer’s disease (AD) and dementia in older adults.
Product Highlights
CME Modules